Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV002294696 | SCV002587597 | likely benign | Atypical hemolytic-uremic syndrome | 2022-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003250500 | SCV003944241 | uncertain significance | Inborn genetic diseases | 2023-03-20 | criteria provided, single submitter | clinical testing | The c.683G>C (p.G228A) alteration is located in exon 5 (coding exon 5) of the CFHR5 gene. This alteration results from a G to C substitution at nucleotide position 683, causing the glycine (G) at amino acid position 228 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |